7 Month 20 Day, the sub-fund invested in by the mother fund managed by Yuanhe Chencun —— Bridge Capital Investment enterprise « Kangpeng Technology 」At Shanghai Stock Exchange STAR Market Listed, stock code: 688602。

Kangpeng Technology was established in In November 1996, the company emerged as a technology-driven enterprise deeply rooted in the fine chemical industry, primarily engaged in the research, development, production, and sales of specialty chemicals. Its product portfolio focuses on advanced materials, as well as pharmaceutical and agrochemicals. Among these, the advanced materials segment encompasses areas such as display materials, next-generation energy storage battery materials, electronic chemicals, and organosilicon products. Meanwhile, the pharmaceutical and agrochemical business operates mainly under a CDMO model, supplying customized pharmaceutical and agrochemical solutions to downstream customers.

Kangpeng Technology's business portfolio is becoming increasingly diversified. In the field of display materials, Kangpeng Technology's flagship product is fluorine-containing liquid crystal monomers, and the company has now risen to become the world's second-largest supplier of liquid crystal mixtures, surpassing its Japanese competitor. JNC is a core supplier and also a key provider for Merck Germany, the world's No. 1 manufacturer of mixed crystals. As the localization of display materials has accelerated in recent years, Kangpeng Technology has established strategic partnerships with leading domestic LCD material manufacturers such as Bayi Yingkong and Jiangsu Hecheng, while actively expanding into OLED display materials.

In the fields of new-energy battery materials and electronic chemicals, Kangpeng Technology is a global leader in independently developing and one of the first companies to achieve mass production of next-generation electrolytes for new-energy batteries. One of the leading companies in "lithium bis(fluorosulfonyl)imide salt (LiFSI)" and the organization spearheading the development of China's industry standards for LiFSI. Our customers primarily include well-known domestic and international battery material or electrolyte manufacturers and traders, such as Xinzebang, Tianci Materials, and Yangzhou Chemicals. Additionally, the company has successfully established production and sales capabilities for several high-performance additives used in next-generation battery electrolytes, including ethylene sulfite.

In the field of silicone materials, Kangpeng Technology has, since Starting in 2016, we began developing silicone materials using our own proprietary technology and gradually ramped up production. Our primary product is silicone pressure-sensitive adhesive, and since 2018, we’ve been actively expanding into the sales market for these adhesives.

In the pharmaceutical and agrochemical sectors, Kangpeng Technology is As early as 1997, the company supplied pharmaceutical intermediates to Eli Lilly USA, and since 2004, it has become the primary supplier of key intermediates for Merck’s sitagliptin. Additionally, Kangpeng Technology has expanded its sales to renowned global companies such as Japan’s Choda and Germany’s Bayer, while also establishing a long-term partnership with Japan’s Choda specifically focused on the innovative insecticide dinotefuran and its related intermediate products.

The funds raised from this IPO will be allocated to the construction of a new materials production base and project R&D, enabling us to ramp up production capacity for our existing flagship products, expand our product portfolio, and strengthen the company’s competitive edge in the market.